TCU Place 35 -22nd St. East, Saskatoon, SK    

<< return to program
Huw Hughes
Pfizer Animal Health
Kalamazoo, MI, USA
Business of Disease Prevention
Wednesday, September 15, 2010
1:30 - 2:00 pm

Abstract: 
Global Animal Health Sales in 2009 were 18.6 billion USD, with the market being split among biologicals (25%), parasiticides (28%), anti-infectives (15%), feed additives (12%) and other pharmaceutical products (20%). The global market for biologicals was 4.7 billion USD in 2009. Since 2002, the global biological market has increased by 3.4% per annum.

The development of biological products for animal health requires flexibility at all stages of the process, from discovery through to manufacturing. Vaccine production systems may vary from the growth of infectious agents in animals through to the most sophisticated methods for the production and purification of DNA, with 40 or more different products (with many hundred SKUs) being produced and released from a single manufacturing site. Additionally, multiple registration authorities with different demands for efficacy, safety, and quality may inhibit the development of truly global products. Emerging infectious diseases such as Bluetongue virus, pH1N1 influenza, West Nile virus, Q fever, etc. mandate a rapid and robust regional response for effective control. New manufacturing processes are discussed that allow for a fluid and, where necessary, rapid response to field situations.
Biography
Huw Hughes is Director of Biological Process Development for Pfizer Animal Health. He is responsible for the development of new products and the implementation of new technology. Huw is also responsible for the Formulation and Pilot laboratories. His team takes veterinary biological products from Proof of Concept through to industrialization.

Huw has over 20 years experience in Veterinary Biological Development, working at Merial, Intervet/Schering and Mallinkrodt prior to Pfizer. He has developed products for all major veterinary species (including fish). He has also worked in Human Health, both in St. George’s Hospital and the Holt-Christie Radium Institute where he studied parasitic diseases and cancer immunology.

Huw has a B.S. in Agricultural Zoology and a Ph.D. in Immunology from Leeds University, in the UK.


Click to view Huw Hughes' ABIC 2010 presentation